ENDRA Life Sciences (NDRA) Competitors $4.72 +0.11 (+2.39%) As of 03:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock NDRA vs. XAIR, FEMY, LYRA, SINT, TNON, PAVM, LFWD, SSKN, POAI, and STRRShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include Beyond Air (XAIR), Femasys (FEMY), Lyra Therapeutics (LYRA), Sintx Technologies (SINT), Tenon Medical (TNON), PAVmed (PAVM), Lifeward (LFWD), Strata Skin Sciences (SSKN), Predictive Oncology (POAI), and Star Equity (STRR). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. Its Competitors Beyond Air Femasys Lyra Therapeutics Sintx Technologies Tenon Medical PAVmed Lifeward Strata Skin Sciences Predictive Oncology Star Equity Beyond Air (NASDAQ:XAIR) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment. Do institutionals & insiders believe in XAIR or NDRA? 31.5% of Beyond Air shares are held by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are held by institutional investors. 19.4% of Beyond Air shares are held by company insiders. Comparatively, 0.0% of ENDRA Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, XAIR or NDRA? ENDRA Life Sciences has lower revenue, but higher earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyond Air$3.70M3.46-$46.62M-$11.93-0.21ENDRA Life SciencesN/AN/A-$11.51M-$33.89-0.14 Is XAIR or NDRA more profitable? ENDRA Life Sciences has a net margin of 0.00% compared to Beyond Air's net margin of -880.72%. ENDRA Life Sciences' return on equity of -194.14% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets Beyond Air-880.72% -232.61% -115.92% ENDRA Life Sciences N/A -194.14%-127.89% Does the media favor XAIR or NDRA? In the previous week, Beyond Air had 4 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 6 mentions for Beyond Air and 2 mentions for ENDRA Life Sciences. ENDRA Life Sciences' average media sentiment score of 1.45 beat Beyond Air's score of 0.64 indicating that ENDRA Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Beyond Air Positive ENDRA Life Sciences Positive Do analysts prefer XAIR or NDRA? Beyond Air currently has a consensus price target of $11.00, indicating a potential upside of 348.98%. ENDRA Life Sciences has a consensus price target of $50.00, indicating a potential upside of 959.32%. Given ENDRA Life Sciences' higher possible upside, analysts clearly believe ENDRA Life Sciences is more favorable than Beyond Air.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, XAIR or NDRA? Beyond Air has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of -0.14, meaning that its stock price is 114% less volatile than the S&P 500. SummaryBeyond Air beats ENDRA Life Sciences on 9 of the 15 factors compared between the two stocks. Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NDRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.54M$6.82B$5.82B$10.17BDividend YieldN/A1.23%5.69%4.60%P/E Ratio-0.1426.0274.6725.98Price / SalesN/A62.87454.5485.61Price / CashN/A21.6337.0859.91Price / Book0.995.0112.186.31Net Income-$11.51M$176.38M$3.29B$270.86M7 Day Performance10.54%1.17%1.08%3.46%1 Month Performance12.92%3.39%7.32%6.57%1 Year Performance-44.64%12.54%63.11%28.39% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences2.8317 of 5 stars$4.72+2.4%$50.00+959.3%-48.1%$3.54MN/A-0.1420Short Interest ↓Gap UpXAIRBeyond Air4.4158 of 5 stars$2.22+1.8%$11.00+395.5%-70.6%$11.60M$3.70M-0.1970Short Interest ↓Gap UpFEMYFemasys3.0909 of 5 stars$0.36-0.4%$7.33+1,965.1%-68.1%$11.57M$1.63M-0.4130News CoverageShort Interest ↑LYRALyra Therapeutics3.5358 of 5 stars$7.00-0.7%$100.00+1,328.6%-52.8%$11.51M$1.53M-0.2450Positive NewsSINTSintx Technologies1.9802 of 5 stars$4.15-2.1%$28.00+574.7%+38.0%$11.45M$2.89M-0.0840Gap UpTNONTenon Medical2.1203 of 5 stars$1.24-3.9%$5.50+343.5%-60.1%$11.01M$3.28M-0.058Positive NewsShort Interest ↓Gap DownPAVMPAVmed4.2353 of 5 stars$0.49+3.7%$19.00+3,816.7%-72.9%$10.64M$2.99M0.4290News CoverageShort Interest ↑Gap UpLFWDLifeward2.6761 of 5 stars$0.63+2.4%$9.00+1,317.8%-81.7%$9.97M$25.66M-0.2060Short Interest ↓SSKNStrata Skin Sciences2.6341 of 5 stars$2.38+17.2%$6.00+152.1%-50.8%$9.93M$33.56M-0.84120Short Interest ↑Gap UpHigh Trading VolumePOAIPredictive Oncology0.8815 of 5 stars$0.87-4.4%N/A+0.4%$9.53M$1.62M-0.2930Short Interest ↓STRRStar Equity1.1194 of 5 stars$2.72+27.5%$5.00+84.1%+104.8%$8.79M$67.39M-2.66460Gap UpHigh Trading Volume Related Companies and Tools Related Companies Beyond Air Competitors Femasys Competitors Lyra Therapeutics Competitors Sintx Technologies Competitors Tenon Medical Competitors PAVmed Competitors Lifeward Competitors Strata Skin Sciences Competitors Predictive Oncology Competitors Star Equity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NDRA) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
